U.S. Stockpiles Two Bird Flu Vaccines
U.S. government health officials announced earlier this month that two bird flu vaccines are being stockpiled and will be available for shipment within weeks. They said that the bird flu stockpiling is part of their emergency preparations in the event the H5N1 virus, which now primarily infects wild birds, chickens and sometimes cows and other […]
Bird Flu Outbreaks & the WHO/IHR Pandemic Treaty Push
Even as U.S. health agencies and the United Nations World Health Organization (WHO) are being heavily criticized for their botched response to the COVID-19 pandemic,1 2 3 WHO officials are ramping up pressure on all nations to sign a WHO pandemic treaty and amendments to the WHO’s International Health Regulations (IHR), which will give them […]
Novel mRNA Lyme Shots Could Be Released in 2025
Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]
RSV Vaccine Approved by FDA for Adults 60 and Older
The U.S. Food and Drug Administration (FDA) has approved a license for the world’s first respiratory syncytial virus (RSV) vaccine to be given to people 60 years of age and older. Pharmaceutical and biotechnology company GSK (formerly GlaxoSmithKline) has already begun manufacturing doses of the vaccine, which will be sold as early as this fall […]
Pharma Developing Bird Flu Vaccine for Humans As Animals Get Sick
Pharmaceutical companies GSK (formerly known as GlaxoSmithKline), Moderna and CSL Seqirus announced that they are developing and ready to test human vaccines against avian influenza H5N1 (also known as bird flu) as a precautionary measure to prepare for what they believe may be a future pandemic.1 Now that certain strains of H5N1 have infected not […]
Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
